Neurofibromatosis Therapeutic Acceleration Program (NTAP)
The goals of the NTAP project is to accelerate the pace of drug discovery in Neurofibromatosis, a genetic pre-cancer syndrome that causes the growth of neurofibromas throughout affected patients.
NTAP is working with Sage on numerous fronts to accelerate the pace of drug discovery in Neurofibromatosis, a genetic pre-cancer syndrome that causes the growth of neurofibromas throughout affected patients. Broadly Sage is working create a comprehensive data portal for both meta and raw data across all NTAP-funded projects. NTAP investigators upload their data to this site, and the data is opened initially to a small community of investigators. As the data is made publicly available, raw data can be released for broad scientific use.
Explore the Data PortalMore Collaborative Science Projects
The Gray Foundation
The Gray Foundation "Team Science" philanthropic initiative funds a network of researchers to study new approaches for the early detection, diagnosis, and therapy of BRCA-related...
Learn MoreThe First 1000 Days 1kD
The 1kD program is an international effort to better understand executive development in toddlers up to 1000 days old.
Learn MoreAccelerating Medicine Partnership in Alzheimer’s Disease
AMP-AD is a public private partnership designed to use systems biology to identify novel targets for AD treatment
Learn More